Standard Biotools Inc (LAB) support and resistance · rev $174.4M
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
This page maps Standard Biotools Inc (LAB) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
LAB currently screens at market cap $317.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new LAB 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the LAB quote page for the session range and the stock page for the full model.
Not investment advice.